ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

NIH Plans Meeting On Human Subjects Issues In Research

June 30, 1995

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997